VanEck Vectors Generic Drugs ETF (GNRX) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free GNRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVanEck Vectors Preferred Securities Ex Financials ETF declares monthly distribution of $0.1422msn.com - December 4 at 8:32 PMGDIG ETF Stock Price Historyinvesting.com - November 10 at 2:11 AMVanEck Announces Changes to ETF Product Linefinance.yahoo.com - April 18 at 11:09 PMVanEck AEX UCITS ETF (TDT)investing.com - March 3 at 1:12 AMGDXJ VanEck Vectors Junior Gold Miners ETFseekingalpha.com - January 22 at 12:07 AMGeneric Drug ETF Can Dodge Biotech Smackdownsthestreet.com - January 9 at 11:35 PMGeneric Drug ETF Offering Portfolio Curethestreet.com - January 18 at 10:48 PM Get VanEck Vectors Generic Drugs ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for GNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address The AI stock to buy right now (Ad)There are about 350,000 large corporations worldwide. Can you see the potential for this AI company to grow like crazy? Click Here to Get the AI Stock Name GNRX Media Mentions By Week GNRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNRX News Sentiment▼0.000.36▲Average News Sentiment GNRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNRX Articles This Week▼00▲GNRX Articles Average Week Get VanEck Vectors Generic Drugs ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for GNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IBBQ News Today BTEC News Today BIB News Today PSCH News Today BBH News Today PPH News Today IBB News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNRX) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithTruth about Trump you’ve never heardPorter & CompanyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Vectors Generic Drugs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
